Laboratory of Molecular Genetics and Biochemistry, Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634014, Russia.
Laboratory of Repair Enzymes, Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia.
J Immunol Res. 2020 Aug 10;2020:8986521. doi: 10.1155/2020/8986521. eCollection 2020.
The level hydrolysis of myelin basic protein (MBP) by IgG in patients with schizophrenia was studied depending on the clinical features and course of the disease. The patients were grouped according to type of schizophrenia and type of disease course. We found that IgGs isolated and purified from sera of schizophrenia patients' blood hydrolyses human MBP, and the level of this hydrolysis significantly exceeds that of healthy individuals. Detection of protease activity corresponding only to intact IgGs in polyacrylamide gel fragments, together with data of gel filtration of antibodies under conditions of "acid shock" (concordance of optical density profile of IgG with profile of MBP-hydrolyzing activity) and with the absence of any other proteins and bands in gradient SDS-PAGE and in PVDF membrane provides direct evidence that the IgGs from the schizophrenia patients have MBP-hydrolyzing activity. The antibodies-specific proteolytic activity of patients with acute schizophrenia (1.026 [0.205; 3.372] mg MBP/mg IgG/h) significantly exceeds the activity of IgG in patients in remission (0.656 [0.279; 0.873] mg MBP/mg IgG/h) and in healthy individuals (0.000 [0.00; 0.367] mg MBP/mg IgG/h). When comparing the specific activity in patients with different types of disease course, we have found that patients with a continuous course of paranoid schizophrenia (1.810 [0.746; 4.101 mg MBP/mg IgG/h]) had maximal activity values. It can be assumed that the increase in the activity of MBP-hydrolyzing antibodies is due to the activation of humoral immunity in acute schizophrenia.
研究了精神分裂症患者 IgG 对髓鞘碱性蛋白(MBP)的水解水平,这取决于疾病的临床特征和病程。根据精神分裂症的类型和病程类型对患者进行分组。我们发现,从精神分裂症患者血液中分离和纯化的 IgGs 水解人 MBP,且这种水解的水平明显高于健康个体。在聚丙烯酰胺凝胶片段中仅检测到与完整 IgGs 对应的蛋白酶活性,以及在“酸冲击”条件下对抗体进行凝胶过滤的结果(IgG 的光密度谱与 MBP 水解活性的谱一致),并且在梯度 SDS-PAGE 和 PVDF 膜中不存在任何其他蛋白质和条带,这直接证明了来自精神分裂症患者的 IgGs 具有 MBP 水解活性。急性精神分裂症患者的抗体特异性蛋白水解活性(1.026 [0.205;3.372] mg MBP/mg IgG/h)明显高于缓解期患者(0.656 [0.279;0.873] mg MBP/mg IgG/h)和健康个体(0.000 [0.00;0.367] mg MBP/mg IgG/h)的 IgG。在比较不同病程类型患者的特异性活性时,我们发现持续偏执型精神分裂症患者(1.810 [0.746;4.101 mg MBP/mg IgG/h))的活性值最大。可以假设 MBP 水解抗体活性的增加是由于急性精神分裂症中体液免疫的激活。